publicações selecionadas
-
artigo académico
- Psychological Distress, Resilience, and Immunoinflammatory Signatures in Healthcare Workers During COVID-19. Journal of Affective Disorders. 2026
- Immune and Long Interspersed Nuclear Element-1 Dysregulation in Schizophrenia: An Exploratory Case–Control Study in a Brazilian Cohort with Ultra-Treatment Resistance. Schizophrenia Bulletin. 2025
- Cord blood cytokines/chemokines linked to delays in toddlers exposed to SARS-CoV-2 prenatally. Pediatric Research. 2025
- Maternal Immunization Against SARS-CoV-2 and Infant Immunity Persistence in a Brazilian Cohort. Pediatric Infectious Disease Journal. 2025
- Age and sex-dependent gut alterations in mice induced by neonatal immune activation with lipopolysaccharide. Journal of Neuroimmunology. 2024
- Hippocampal cholinergic receptors and the mTOR participation in fear-motivated inhibitory avoidance extinction memory. Behavioural Brain Research. 2023
- Cannabidiol-induced autophagy as an underlying mechanism for its immunoregulatory action on activated human microglia.. Neuroscience Applied. 2022
- Modulation of the extinction of two different fear-motivated tasks in three distinct brain areas. Behavioural Brain Research. 2012
- Treatment of fear memories: Interactions between extinction and reconsolidation. Anais da Academia Brasileira de Ciências. 2011
- Molecular mechanisms in hippocampus and basolateral amygdala but not in parietal or cingulate cortex are involved in extinction of one-trial avoidance learning.. Neurobiology of Learning and Memory. 2010
- Neuromodulatory effect of creatine on extracellular action potentials in rat hippocampus: role of NMDA receptors. Neurochemistry International. 2008
- The involvement of the polyamines binding sites at the NMDA receptor in creatine-induced spatial learning enhancement. Behavioural Brain Research. 2008
- Cyclooxygenase2/PGE2 pathway facilitates pentylenetetrazol-induced seizures.. Epilepsy Research. 2008
- Creatine decreases convulsions and neurochemical alterations. Brain Research. 2007
- GM1 ganglioside induces vasodilation and increases catalase content in the brain. Free Radical Biology and Medicine. 2007
- The role of nitric oxide on the convulsive behavior and oxidative stress induced by methylmalonate: An electroencephalographic and neurochemical study. Epilepsy Research. 2007
- Methylene blue prevents methylmalonate-induced seizures and oxidative damage in rat striatum. Neurochemistry International. 2007
- GM1 ganglioside prevents seizures, Na+,K+-ATPase activity inhibition and oxidative stress induced by glutaric acid and pentylenetetrazole. Neurobiology of Disease. 2006
- Effectiveness of creatine monohydrate on seizures and oxidative damage induced by methylmalonate. Pharmacology Biochemistry and Behavior. 2006
- Involvement of NO in the convulsive behavior and oxidative damage induced by the intrastriatal injection of methylmalonate. Neuroscience Letters. 2005
- Ascorbate modulates pentylenetetrazol-induced convulsions biphasically. Neuroscience. 2004
-
capítulo de livro
-
documento
- Non-invasive profiling of Fabry disease: molecular fingerprints from plasma and extracellular vesicles 2026
- Exploring Inflammatory Patterns in Fabry Disease Using Extracellular Vesicle Cytokine Profiling 2025
- Differential miRNA Expression in Plasma Vesicles Across Fabry Disease Phenotypes 2025
- Mapping inflammatory patterns in Fabry disease through EVs-associated cytokine profiling 2025
- "Shared neuroimmune signatures in SARS-CoV-2 placenta and schizophrenia peripheral blood: parallel dysregulation of GPER1 and HERV-W gene expression. 2025
- Shared neuroimmune signatures in SARS-CoV-2 placenta and schizophrenia peripheral blood: parallel dysregulation of GPER1 and HERV-W gene expression 2025
- Extracellular Vesicle miRNA Signatures in Fabry Disease 2025
- Cytokine Profilling in Fabry Disease: Insights from Free and EV Associated Profiles 2025
- Cytokine Profilling in Fabry Disease: Insights from Free and EVAssociated Profiles 2025
- CYTOKINE BIOSIGNATURE AS PREDICTORS OF NEURODEVELOPMENTAL OUTCOMES IN INFANTS EXPOSED TO SARS-COV-2 2024
- FACTORS INFLUENCING THE DEVELOPMENT AND WORSENING OF COMMON MENTAL DISORDERS IN HEALTHCARE WORKERS DURING THE COVID-19 PANDEMIC: THE ROLE OF CYTOKINE PROFILES AND COPING STRATEGIES 2024
- ANTIDEPRESSANT EFFECT OF CANNABIS COMPOUNDS IN AN INFLAMMATORY MODEL OF DEPRESSION INDUCED BY REPEATED ADMINISTRATION OF LPS 2023
- A brain neoplasm follow-up in a tertiary public hospital of northeast of Brazil: 2014-2016 data 2023
- On the participation of hippocampal cholinergic system and mTOR in fear memory extinction 2022
- INQUÉRITO SOROEPIDEMIOLÓGICO PARA SARS-COV-2 EM PROFISSIONAIS DE SAÚDE DO ESTADO DO CEARÁ 2021
- O PESO DE UMA EXTRAÇÃO 2021
- On the PArticipation of Different Neuromodulatory Systems in the Hippocampus, Basolateral Amygdala an Ventromedial Prefrontal Cortex in the Extinction of Fear Memories 2011
- Molecular Mechanisms in Hippocampus and Basolateral Amygdala but not in Parietal or Cingulate Cortex are Involved in Extinction of One-trial Avoidance Learning 2011
- Parallel memory processing by the CA1 region of the dorsal hippocampus and the basolateral amygdala 2008
- Efeito da Perfusão Transcardíaca sobre o Aumento da Atividade da Catalase Cerebral Induzido por GM1 2006
- Ascorbato modula de maneira bifásica as convulsões induzidas por pentilenotetrazol 2004
- Efeito do MK-801 sobre as convulsões, carbonilação protéica e lipoperoxidação induzidas por ácido metilmalônico 2004
- Creatina causa prejuízo da memória na tarefa de esquiva inibitória 2004
- Efeito do L-NAME sobre as convulsões e carbonilação protéica total induzida por ácido metilmalônico 2004
- Convulsões induzidas por pentilenotetrazol são moduladas de maneira bifásica por ascorbato 2004
- Creatina causa prejuízo na memória e dependência de estado na tarefa de esquiva inibitória 2004
- Efeito do L-NAME sobre as convulsões, carbonilação protéica induzidas por ácido metilmalônico 2004
- Efeito do MK-801 sobre as convulsões e a carbonilação protéica induzidas por ácido metilmalôncio (MMA) 2004
- Gangliosídeo GM1 previne a produção de substâncias do ácido tiobarbitúrico e a carbonilação protéica induzidas pelo ácido glutárico em ratos 2004
- Gangliosídeo GM1 previne as convulsões e a inibição da atividade de Na+, K+ - ATPase induzida pelo ácido glutárico em ratos 2004